Overview

Prevention of Severe Postpartum Hypertension

Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether postpartum administration of furosemide to women with antepartum hypertensive disorders (gestational hypertension, preeclampsia) or elevated blood pressure in the first 24 hours following delivery reduces severe postpartum hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University
Washington University School of Medicine
Treatments:
Furosemide